Align Technology sets Q2 earnings date, shares trade steadily on Nasdaq

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-29, 15:22.

Align Technology (US0162551016) is approaching its next earnings update on the Nasdaq, with investors focusing on how clear aligner demand trends feed through into margins. Analyst estimates for the coming quarters outline a cautious recovery path in the dental and orthodontics market, according to MarketScreener consensus data.MarketScreener consensus for Align Technology

What analysts currently expect

MarketScreener shows that around 20 analysts cover Align Technology, with a majority of ratings sitting in the Buy or Outperform category and a smaller group at Hold.MarketScreener analyst overview Consensus points to mid-single-digit revenue growth for the current year, reflecting a gradual normalization in orthodontic procedure volumes after the more volatile pandemic years.Reuters key metrics for ALGN

On the earnings side, the current estimates imply a price-to-earnings multiple in the high-20s to low-30s range, which puts Align broadly in line with other high-margin medical technology peers rather than the more richly valued software names in the Nasdaq-100.AltIndex valuation snapshot for ALGN The implied margin profile remains sensitive to mix between premium Invisalign cases and lower-priced offerings, which analysts flag as a key lever for the next two years.Financial Times commentary on dental device margins

Upcoming earnings and sector backdrop

Align Technology is expected to report its next quarterly results toward the end of July, in line with its usual late-month pattern, with the exact date to be confirmed on the company’s investor relations calendar.Align Technology IR quarterly results page Investors will compare Align’s updates with those from dental peers such as Straumann and Dentsply Sirona, which offer a useful reference for procedural demand in orthodontics and implant dentistry.Reuters key metrics for Straumann

According to AltIndex, Align Technology’s market capitalization currently stands at around 12.8 billion US dollars, with the shares recently quoted at about 175 dollars and a trailing price-to-earnings ratio of roughly 30.AltIndex data on ALGN That puts the company in the mid-cap bracket of the broader US healthcare equipment universe, below giants such as Medtronic but with a more focused business model concentrated on digital orthodontics.Reuters sector overview for healthcare equipment

The product behind the stock

Align Technology generates the bulk of its revenue from its Invisalign clear aligner system, which is used by orthodontists and dentists to correct teeth alignment through a series of custom-made, removable plastic trays.Align Technology corporate overview The company complements Invisalign with iTero intraoral scanners and CAD/CAM software, enabling digital treatment planning and data storage for dental practices.Align Technology investor presentation

Where the shares trade today

Align Technology shares (US0162551016) trade on the Nasdaq exchange, with recent quotations around 175 US dollars per share as of 2026-06-27, 16:00 US Eastern time.AltIndex price data for ALGN

Disclaimer: This text is for informational purposes only and does not constitute investment advice, a recommendation to buy or sell securities, or any other form of financial guidance. All data were obtained from sources deemed reliable but cannot be guaranteed for accuracy or completeness.